Related Experiment Videos
Guanfacine: a new centrally-acting antihypertensive agent
Pharmatherapeutica
|January 1, 1981
Summary
Guanfacine effectively lowers blood pressure in hypertensive patients, with minimal side effects at doses below 3 mg daily. This centrally-acting antihypertensive drug shows promise for managing hypertension.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Clinical Therapeutics
Background:
- Hypertension remains a significant global health concern, necessitating effective and safe treatment options.
- Centrally-acting antihypertensive agents offer a distinct mechanism for blood pressure management.
Purpose of the Study:
- To evaluate the efficacy and safety of guanfacine in patients with moderate to severe hypertension.
- To determine the optimal dosage range for guanfacine to balance therapeutic effects and side effects.
Main Methods:
- A clinical study involving 11 patients with moderate hypertension and 6 patients with severe, treatment-resistant hypertension.
- Administration of guanfacine at daily doses of 2 mg and 3 mg, with monitoring of blood pressure, plasma renin activity, and side effects.
Main Results:
- An average reduction of 10.8 mmHg in diastolic blood pressure was observed in moderate hypertensives with 2 mg daily dose.
- A 7 mmHg reduction in diastolic pressure was achieved in severe hypertensives using 3 mg daily.
- Side effects were minimal below 3 mg/day, including a slight weight gain (1.8 kg) and a fall in plasma renin activity.
Conclusions:
- Guanfacine is an effective antihypertensive drug for mild to moderate hypertension.
- Doses below 3 mg daily are associated with few side effects, making it a potentially useful therapeutic option.
- Higher doses (above 3 mg/day) may lead to prominent side effects such as sedation, dry mouth, and constipation.